Literature DB >> 31204661

Long-Term Benefits of Dose-Escalation in Localized Prostate Cancer.

Daniel E Spratt1, Jeff M Michalski2.   

Abstract

Entities:  

Year:  2019        PMID： 31204661     DOI： 10.1016/j.ijrobp.2019.04.001

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  2 in total

1.  Moving Beyond the Standard of Care: Accelerate Testing of Radiation-Drug Combinations.

Authors:  Steven H Lin; Henning Willers; Sunil Krishnan; Jann N Sarkaria; Michael Baumann; Theodore S Lawrence
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-08-25       Impact factor: 8.013

2.  Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trials.

Authors:  Tommy Jiang; Daniela Markovic; Jay Patel; Jesus E Juarez; Ting Martin Ma; David Shabsovich; Nicholas G Nickols; Robert E Reiter; David Elashoff; Matthew B Rettig; Nicholas G Zaorsky; Daniel E Spratt; Amar U Kishan
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-08-16       Impact factor: 5.554
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.